Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionDual glucagon-like peptide-1 (GLP-1) and glucagon receptor (GCGR) agonist
Molecular Target Glucagon-like peptide-1 (GLP-1) ; Glucagon receptor (GCGR)
Mechanism of ActionGlucagon receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today